门诊管理的慢阻肺急性加重期居家肺康复的短期随机对照试验
结果显示居家肺康复组在CAT评分及13项次要结局中的12项改善显著优于对照组,且自我感知获益正面、无不良事件。
要点
- 门诊管理的慢阻肺急性加重患者中,3周居家肺康复较常规护理显著改善CAT评分(Δ-12.5 vs Δ-5.9,p=0.002)。
- 13项次要结局中12项显示居家肺康复组改善显著优于对照组。
- 居家肺康复自我感知对症状、日常控制、健康、心理状态和赋能均有正面影响,未报告不良事件。
核心结论
- 3周居家肺康复方案安全、有意义,在改善症状、功能能力和健康状况方面优于单纯标准药物治疗。
主要发现
- 实验组CAT评分改善显著大于对照组(Δ-12.5±7.2 vs Δ-5.9±7.2,p=0.002)。
- 13项次要结局中12项显示实验组改善显著优于对照组。
- 自我感知肺康复对症状、日常生活的控制、健康、心理状态和赋能均有正面影响。
- 未报告不良事件。
临床怎么用
- 对门诊管理的慢阻肺急性加重患者,可考虑在常规治疗基础上提供3周居家肺康复以改善短期症状、功能能力和健康状况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Uncertainty exists about the beneficial effects of delivering pulmonary rehabilitation (PR) during exacerbations of chronic obstructive pulmonary disease (ECOPD). This study explored the short-term effects and self-reported impact of a home-based PR programme for people with outpatient-managed ECOPD. METHODS: We conducted a mixed-methods randomised controlled trial in people with outpatient-managed ECOPD. Participants were randomly assigned to the control (CG, ie, usual care) or experimental (EG, ie, usual care and 3-week home-based PR) group within 48 hours of the diagnosis (baseline). Assessments were performed at baseline and after 3 weeks (post). The COPD assessment test (CAT) was the primary outcome. Secondary outcomes included measures of symptoms and functional capacity. After PR, interviews were conducted. Analyses were performed using (non-)parametric mixed analysis of variance, deductive thematic analysis and narrative integration through joint displays. RESULTS: Fifty participants with outpatient-managed ECOPD (78% men, 70±11 years, forced expiratory volume in one second 47.4±16.4% pred) were included. Significant greater improvements in the EG compared with the CG were found for the CAT (EG Δ-12.5±7.2 vs CG Δ-5.9±7.2, p=0.002) and 12 of 13 other secondary outcome measures. A positive self-perceived impact of PR was found on symptoms, control of daily life, health, mental status and empowerment. No adverse events were reported. CONCLUSIONS: A 3-week home-based PR programme is safe, meaningful and more effective than just standard medication in improving symptoms, functional capacity and health status, outcomes often associated with poor prognosis. This highlights the role of PR in improving the recovery process during outpatient-managed ECOPD and might contribute to a better prognosis in these individuals. TRIAL REGISTRATION: NCT03751670.
引用
- Machado A, Dias C, Paixão C, et al. Short-term effects of home-based pulmonary rehabilitation during outpatient-managed exacerbations of COPD: a randomised controlled trial. Thorax. 2025. PMID: 39689939. doi:10.1136/thorax-2024-221760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。